Home About Us Contact Us

 

Table of Content - Volume 15 Issue 3 - September 2020

 

 

Type II Diabetes and sensorineural hearing loss

 

Preeti S. Raga1*, Amrith Waghray Lal2, Shruti Mohanty3

 

{1Associate Professor, 2Professor, Department of ENT} {3Professor, Department of Biochemistry} Kamineni Institute of Medical Sciences, Kamineni Staff  Quarters Kamineni Campus, Narketpally, Dist. Nalgonda, Telangana, INDIA.

Email: dr.preetiraga.or@gmail.com, amrith49@gmail.com

 

Abstract              Background: To compare hearing acuity in patients suffering from diabetes mellitus with normal subjects by pure tone audiometry. Objectives: 1. To assess hearing in Normoglycemic subjects and Hyperglycemic subjects by pure tone audiometry. 2. To compare the auditory acuity of diabetics and nondiabetic subjects. 3. To analyse whether the uncontrolled diabetes and the duration of diabetes mellitus, is related to the severity of hearing loss. Methods: A study was done with fifty type 2 diabetes mellitus patients between ages of 30-50 years attending the diabetic OP, and fifty non diabetic (Control) people matched with age and sex, attending the master health check-up scheme at Kamineni Institute of Medical Sciences Naketpally Nalgonda district Telangana, India. The following investigations such as fasting and postprandial blood sugar, glycosylated haemoglobin (HbA1C) and pure tone audiometry were carried out in all the patients. Results: The number of patients affected with sensorineural deafness among the diabetics were 88% when compared to that of the controls 8%, which is highly significant (P = 0.001). The audiograms of the diabetics were suggestive of mild to moderate sensorineural deafness and the hearing loss was more towards the higher frequencies. Conclusion: The diabetic patients showed significant high frequency, bilateral, mild to moderate sensorineural hearing loss (88%) as compared to the controls of similar age. The glycaemic status have significant correlation with the hearing loss but duration of diabetes have no significant correlation with hearing loss and both the sexes were equally affected.

Key Word: Audiometry, HbA1c, Sensorineural hearing loss, Type 2 diabetic mellitus

 

INTRODUCTION

Diabetes mellitus is the one of the endocrine disorder most commonly related with auditory diseases. The mortality and morbidity is mainly due to long term micro and macro vascular complications affecting the blood vessels of eyes, kidneys, heart and nerves1,24 and it has been postulated that the micro vascular complications also affect the hearing of diabetes patients. Studies have demonstrated thickening of the basement membrane of the capillaries of stria vascularise2 in diabetic animals. Histopathological studies have shown damage to the nerves and vessels of the inner ear of the individuals with diabetes. These vascular changes have been theorized to be an important causative factor for neuronal degeneration in the auditory system3,25. Few studies implicated diabetes mellitus as independent causative factor of sensorineural hearing loss4. Many different types of hearing loss has been found in diabetic patients; one of them is progressive, gradual bilateral sensorineural loss, affecting especially high frequencies and the elderly. It would be similar to presbycusis, but with more severe losses than those expected by aging5. Conversely, there are authors who report the possibility of having early sensorineural loss6. Some studies described diabetes as the possible cause of sudden hearing loss7. The probable mechanisms of hearing losses are microangiopathy of the inner ear, neuropathy of the cochlear nerve, a combination of both, outer hair dysfunction and disruption of endolymphatic potential.

The following pathological changes were observed in diabetic patients with sensorineural hearing loss by various authors

  1. Severe atrophy of the spiral ganglion in the basal and middle turns of the cochlea, the 8th nerve changes of myelin degeneration with fibrosis, (Makishima and Tanaka 1971)8.
  2. Thickening of the walls of the vasa nervorum of 8th nerve, leading to acoustic neuropathy (Jorgensen 1961) 9.
  3. Microangopathic changes in the endolymphatic sac, stria vascularis and basilar membrane (Wackym and Linthicum 1986)10.
  4. A mutation in mitochondrial tRNA in a small subset of patients with maternally inherited diabetes with sensorineural hearing loss (Van den Ouweland et al. ) [11 ].
  5. Abnormalities of outer hair cell function. and abnormal auditory brain stem responses in patients with diabetes,( Lisowska et al.).12
  6. Fukushima et al.3 concluded that Type 2 Diabetes results in changes in cochlea, such as significant atropy of stria vascularis and otic loss in basal turn, which likely results in hearing loss.

 

MATERIALS AND METHODS

 100 (Subjects) were classified into two Groups. Group I (n=50) subjects, Group II (n =50) type. Group I (n=50) Type 2 diabetic patients from Medical out patients and group II (n=50) non – diabetic healthy (control) people, matched with age and sex, visiting the master health check-up scheme at Kamineni Institute of Medical Sciences Naketpally Nalgonda district Telangana India, attended hospital between January 2018 to February 2019.

Inclusion criteria were type 2 diabetic patients between age 30 to 50 years and non-diabetic, age and sex matched healthy subjects with no previous history of ear diseases.

Exclusion criteria were family history of hearing loss, history of chronic suppurative otitis media, meningitis, head or ear trauma, history of ear surgeries performed in the past, and history of ototoxic drug intake, and systemic diseases like hypertension, cardiac diseases , renal failure and occupational noise exposure. Written consent was obtained from all the subjects enrolled in the study after explaining to them in detail about the study in their own language. The study was approved by the institutional Ethical committee Kamineni Institute of Medical Sciences Narketpally, Nalgonda district, Telangana. Hearing assessment was done by clinical history, ear examination including tuning fork tests and Pure Tone Audiometry (Audiometer model 500 MK III of Arphi company in a sound proof room in the ENT department of Kamineni Institute Of Medical Sciences Narketpally, Nalgonda district Telangana ) to determine hearing function, the degree, type and configuration of a hearing loss if any.

 

Biochemical parameters for diabetes

The new cases were considered as diabetics when their fasting blood glucose value was > 126 mg/dL and post prandial plasma glucose was > 200 mg/dL. HbA1c level were determined in all the subjects. Data was statistically analysed using Pearson correlation coefficient. The subjects also underwent the following tests,

Statistics: Student t test has been used to find the significance of auditory thresholds (dB) between various categories of parameters. Analysis of variance [ANOVA] has been used to find the significance of auditory thresholds in different groups. The statistical software namely SPSS 11.0 was used for the analysis of the data and Microsoft Word and Microsoft Excel have been used to generate graphs, tables, etc. Table.1. Compares the glycemic levels in groups I and II which is highly significant (P = 0.001). Using the Chi square test the number of people affected with sensorineural deafness among the diabetics is 88% (44/50) when compared to that of the controls (8%, 4/50) which is highly significant (P=0.001).


 

OBSERVATION AND RESULTS

More number of patients was seen in 46-50 years of age group and 60% were females (Table 1 and 2)

 

TABLE I: Age distribution (N=100)

Age (in years)

Total Number (n=100)

Diabetic

(n=50)

Normal

(n=50)

30-35

20

10

10

36-40

20

10

10

41-45

20

10

10

46-50

40

20

20

More number of diabetic patients were seen in 46-50 years of age group.

 

Graph I: Age distribution

 

TABLE=II:  Sex distribution ( n=100)

Sex

Total Number

(n=100)

Diabetic

(n=50)

Normal

(n=50)

Male

40

20

20

Female

60

30

30

40% of cases and controls are men and 60% are women.

 

Table III: Blood Sugar level (n=100)

Sugar parameters

Controls

(Mean± SD)

Cases(Diabetic)

(Mean ±SD)

FBS

(normal= 70-110 mg/dl)

 

76.7± 6.34

 

164.4± 60.56

PPBS

(Normal=100-140mg/dl)

 

107.0±8.76

 

218.3±90.26

Differences in the fasting blood sugar and post prandial blood sugar level between the cases and controls were clinically Significant. Patients with hyperglycemia have their levels of blood sugar about twice that of control.

 

Table IV: Sugar levels Compares the glycemic levels in groups I and II

Groups

Fasting blood sugar

(mg/dL)

Mean ± SD

Postprandial

Blood sugar

(mg/dL)

Number of

Subjects with

Hearing loss

Group I controls (n = 50)

80.8 ± 11.43

106.7 ± 14.8

4 ( 8%)

Group II Diabetics (n = 50)

181.47 ±9.93

286.8 ± 103.3

44(88%)

 The number of people affected with sensorineural deafness among the diabetics is 88% (44/50) when compared to that of the controls (8%, 4/50) which is highly significant (P = 0.001).

 

Table V: Effect of diabetes mellitus on auditory thresholds in db

Frequency in Hz

Auditory Thresholds in dB : normal threshold is less than or equal to 25 db [WHO]

 

Normal (n = 50)

(Mean ±SD)

Diabetic (n = 50)

(Mean ±SD)

250

18.1 ±3.82

25.7± 8.81*

500

18.5± 4.36

26.6± 9.61 *

1000

17.3± 4,17

28.3± 8.86 *

1500

16.3± 6.13

28.5± 9.34 *

2000

16.3± 6.13

28.1± 9.24 *

3000

18.0± 3.48

30.8± 7.34*

4000

17.2± 3.71

34.1± 10.79*

6000

17.8± 3.12

36.0± 12.19*

8000

18.5± 4.06

34.6± 13.53*

 *Statistically significant by student t test

 

Graph II: Effect of diabetes mellitus on auditory thresholds in db

 

Table VI: Auditory thresholds (db) in HbA1c-wise subgroups of diabetics (Mean ± SD)

Frequencies

in hertz

Hb A1c good control

<6-8%> n=26

Hb A1c poor control

>8% n=24

p value

250

25.75 ±5.91

32.62 ±7.18

0.010*

500

29.50 ±4.97

34.44 ±7.55

0.021*

1000

26.13 ±6.31

32.78 ±9.69

0.016*

1500

23.38 ± 5.27

30.00 ± 9.19

0.009*

2000

26.38 ±7.28

33.78 ± 8.41

0.006*

3000

23.88 ±6.76

32.42 ±7.89

0.001*

4000

30.68 ±8.91

39.44 ±8-93

0.004*

8000

29.88 ±11.02

41.94 ±11.59

0.001*

*Statistically significant

Graph III: Auditory thresholds (db) in HbA1c-wise subgroups of diabetics

As shown in table and graph V, from 250-8000 Hz frequency, there was a significant difference between diabetic patients with good control of their blood sugars [HbA1c <6-8%] versus diabetic patients with poor control of their blood sugars [HbA1c >8%].The number of patients in good control group were 26 and the poor control were 24.

 

Table VII: Auditory thresholds (db) in duration-wise subgroups of diabetics

Frequency

(Hz)

Auditory thresholds (dB)

 

 

 

Duration of DM <10years (n =34)

Duration of DM

>10years (n = 16)

P value

(student t test)

250

27.73 ± 7.21

33.57 ± 7.34

0.060

500

31.10 ± 7.05

35.36 ± 4.66

0.136

1000

28.60 ± 8.90

32.14 ± 8.83

0.343

1500

26.25 ± 8.19

28.21 ± 9.43

0.576

2000

29.56 ± 8.36

31.07 ± 11.07

0.682

3000

27.31 ± 8.42

28.93 ± 10.29

0.658

4000

33.97 ± 9.28

35.36 ± 13.65

0.742

6000

35.36 ± 10.32

40.36 ± 14.03

0.309

8000

34.71 ± 11.99

37.86 ± 14.96

0.547

The effect of duration of diabetes on hearing threshold was not much significant clinically and statistically.

 


DISCUSSION

This study has evaluated the hearing loss in the patients with diabetes and the influence of hyperglycemia on hearing and it shows that the diabetics had a 88% incidence of deafness when compared to the non- diabetics of the same age group (8%) (Table1). Other studies showed the incidence of hearing loss ranging from 30% to 95%. Friedman et al.13] showed a 55% incidence of hearing loss in diabetic patients. Kakarlapudi et al.14,24,25 found that hearing loss was more common in diabetic patients (13.1% prevalence) than the control. Weng et al.15 noted that among the 67 diabetic subjects examined, 44.8% of them had profound hearing loss.

In his study,the duration of diabetes (above or below 10 years) was found to have no effect in the incidence of hearing loss in the diabetic group(Table VII), whereas the glycemic control was found to have effect in the incidence of hearing loss (HbA1C level above or below 8) (Table VI). Taylor and Irwin (1978)6 observed that female patients with diabetes had significantly greater hearing loss when compared with male patients with diabetes. According to Cullen and Cinnamond (1993)16, male patients with diabetes had worse hearing than female patients with diabetes. In our study we observed no differences between the gender (Table II). Many studies suggested that diabetes causes hearing loss.. In this study, the audiogram analysis of controls and diabetics showed that 8% of the controls had hearing loss (Table IV ) and 44 (88%) of the diabetics had hearing loss(Table V). In our analysis, hearing loss was observed at higher pure tone frequencies at 4000 to 8000 Hz. Audiograms of the diabetic patients had no significant air bone gap and the hearing loss was of the sensorineural type. This result was in concordance with previous studies16, 17,. But Fangchao Ma et al.18 and Friedman et al.12 observed the strongest association of hearing loss at lowest frequency at 500 Hz. Gibbin and Davis17 found a statistically significant incidence of type II tone decay in the overall group of diabetics at 2000Hz. According to Frisina et al.19 the greatest deficit of hearing in the diabetics tended to be at low frequencies. Vaughan et al.20 suggest that diabetic patients 60 years old or younger may show early high frequency loss similar to early presbycusis. Our study reports that the incidence of sensorineural deafness is increased in diabetics.(Table VI) The hearing loss is a progressive, bilateral, sensorineural deafness of gradual onset which affects predominantly the higher frequencies. The decrease in hearing acuity is similar to presbycusis but those affected show a hearing loss greater than could be expected at that age. Among diabetic patients, poorly controlled diabetic group [HbA1c >8%] having more hearing loss in all frequencies when compared with good control diabetic group [HbA1c< 6-8%] (Table VII)

 

CONCLUSION

Though the sample size considered in this study was small, the study offers significant clinical implications. From the study, it was seen that majority of the Diabetes mellitus patients had subclinical hearing loss. The age of the patient and degree of glycemic control had a positive correlation with hearing loss. Gender and duration of diabetes did not have any effect on the hearing status. Health-care providers need to be aware of the coexistence of hearing symptoms and incorporate audiological referral as a routine practice in future for every patient with DM. Future studies are needed to understand the existence of central auditory processing deficits or auditory neuropathy in these individuals and to note the change in hearing threshold with an improvement in glycemic control.

 

Declaration: I declared that, in this study there is no conflict of interest, no Sponsorships, no funding done .Informed consent was obtained from all individual participants included in the study. Animal rights - not applicable. Plagiarism –not done/not crossed the limit. Ethical  clearance from institutional Ethical comity.

 

REFERENCES

  • Eric P.Widmaier et al.. Vander, Sherman, Luciano’s Human physiology: The mechanisms of body function. 9th edition, pp 231-238, McGraw Hill, 2004.
  • Allen G Kerr, Dafydd Stephans. Scott-Brown’s Otolaryngology: Adult Audiology; volume 2; 6th edition, pp 2/1/6-9, Butterworth Heinemann, 1997.
  • Fukushima H, Cureoglu S,et al.l. Effects of type 2 diabetes mellitus on cochlear structure in humans. Arch Otolaryngol Head Neck Surg. 2006 Sep;132(9):934-8.
  • King H, Aubert E T, Herman W H. Global burden of diabetes 1995-2025: Prevalence, Numerical estimations and projections. Diabetes care 1998; 21: 1414-1431.
  • Harris M I. Undiagnosed NIDDM: Clinical and public health issues. Diabetes care 1993; 16:642-652.
  • IG Taylor at all. Some audiological aspects of diabetes mellitus. J Laryngol Otol. 1978 Feb;92(2):99-113.
  • Bradford L J, Hardy W G. Hearing and hearing impairment pp 1-19, Grune and Stratton 1979.
  • Makishima K, Tanaka A K. Pathological changes of the inner ear and central auditory pathways in diabetics. Oto Rhinolaryngol 1981; 80 (2): 218-228.
  • Jorgensen B. The inner ear in diabetes mellitus. Arch Otolaryngol Head Neck Surg. 1961; 74: 31-39.
  • Wackym P A, Linthicum F H Jr. Diabetes mellitus and hearing loss: clinical and histopathological relationships. The American journal of otology 1986; 7(3): 176-182.
  • Van den Ouweland et al.l .tRNA gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1, 368–371 (1992). https://doi.org/10.1038/ng0892-368
  • Graz˙yna Lisowska. Early Identification of Hearing Impairment in Patients With Type 1 Diabetes Mellitus. Otology and Neurotology 22:316–320(2001)
  • Friedman S A, Schulman R H, Weiss S. Hearing and diabetic neuropathy. Arch Intern Med 1975 April: 135: 573-576.
  • Kakarlapudi Venkata, Sawyer R, Staecker H. The effect of diabetes on sensorineural hearing loss. Otology and Neurology 2003; 24 (3): 382-386.
  • Weng et al.l.Risk of developing sudden sensorineural hearing loss in diabetic patients: a population-based cohort study. Otol Neurotol. 2012 Dec;33(9):1482-8.
  • Cullen and Cinnamond . Hearing loss in diabetics .The Journal of Laryngology and Otology March 1993; 107( 3) pp. 179-182
  • GibbonK. P.DavisC. G. A hearing survey in diabetes melitus Clinical Otolaryngology 6(1981) : 345–350Google Scholar
  • Naufal P M. Schuknecht H F. Neuropathy in diabetes mellitus. Arch Otolaryng. 1972; 96: 468-473.
  • Frishina et al.l. Interactions of hearing loss and Diabetes Mellitus in the middle age CBA/CaJ mouse model of presbycusis. Hear Res. 2009 Mar; 249(1-2): 44–53.
  • Snell Richard S. Clinical Anatomy. 7th edition, pp 834-841, Lippincott Williams and Wilkins, 2003.
  • Charles W Cummings, John M Fredrickson. Otolaryngology and Head and Neck surgery; volume 4; 3rd edition., pp 2803-2929, Mosby 1998.
  • Ganong W F. Review of Medical Physiology. 21st edition. pp 173-186, McGraw Hill, 2003.
  • Lasisi O A, Nwaorgu O G B, Bella A F. Cochleovestibular complications of diabetes mellitus in Ibedan, Nigeria. International Congress Series 1240 (2003); 1325-1 328(2003 International federation of otorhinolaryngological societies [IFOS]).
  • Horikawa C, Kodama S, Tanaka S, Fujihara K, Hirasawa R, Yachi Y, et al. Diabetes and risk of hearing impairment in adults: A meta-analysis. J Clin Endocrinol Metab 2013; 98:51-8.
  • Aniruddh Tiwari, Ramesh S Mudhol .Prevalence of sensorineural hearing loss among type-II diabetes mellitus patients attending KLES Dr. Prabhakar Kore Hospital and MRC: A cross-sectional study. IJOURNALHS.May-August 2018;
    11( 2):165-169.

 





 


 



 

 

Policy for Articles with Open Access
Authors who publish with MedPulse  International Journal of ENT(Print ISSN: 2579-0854) (Online ISSN: 2636- 4727) agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.